nodes	percent_of_prediction	percent_of_DWPC	metapath
Molindone—DRD2—nicotine dependence	0.883	1	CbGaD
Molindone—Extrapyramidal symptoms—Varenicline—nicotine dependence	0.00753	0.131	CcSEcCtD
Molindone—Libido increased—Varenicline—nicotine dependence	0.00642	0.112	CcSEcCtD
Molindone—Extrapyramidal disorder—Varenicline—nicotine dependence	0.00519	0.0904	CcSEcCtD
Molindone—DRD2—Nicotine Activity on Dopaminergic Neurons—CHRNA6—nicotine dependence	0.00421	0.0793	CbGpPWpGaD
Molindone—Leukocytosis—Varenicline—nicotine dependence	0.00416	0.0724	CcSEcCtD
Molindone—Salivary hypersecretion—Varenicline—nicotine dependence	0.00379	0.0661	CcSEcCtD
Molindone—Euphoric mood—Varenicline—nicotine dependence	0.00336	0.0585	CcSEcCtD
Molindone—Disturbance in sexual arousal—Varenicline—nicotine dependence	0.00281	0.049	CcSEcCtD
Molindone—DRD2—Nicotine Activity on Dopaminergic Neurons—CHRNA5—nicotine dependence	0.00271	0.0511	CbGpPWpGaD
Molindone—Urinary retention—Varenicline—nicotine dependence	0.0027	0.047	CcSEcCtD
Molindone—Dysphagia—Varenicline—nicotine dependence	0.00245	0.0427	CcSEcCtD
Molindone—Weight increased—Varenicline—nicotine dependence	0.00223	0.0389	CcSEcCtD
Molindone—DRD2—Nicotine Activity on Dopaminergic Neurons—CHRNA3—nicotine dependence	0.00221	0.0416	CbGpPWpGaD
Molindone—DRD2—Nicotine Activity on Dopaminergic Neurons—CHRNB2—nicotine dependence	0.00195	0.0367	CbGpPWpGaD
Molindone—DRD2—Nicotine Activity on Dopaminergic Neurons—CHRNA4—nicotine dependence	0.00177	0.0333	CbGpPWpGaD
Molindone—Muscle spasms—Varenicline—nicotine dependence	0.00164	0.0286	CcSEcCtD
Molindone—Vision blurred—Varenicline—nicotine dependence	0.00161	0.028	CcSEcCtD
Molindone—Tremor—Varenicline—nicotine dependence	0.0016	0.0279	CcSEcCtD
Molindone—Agitation—Varenicline—nicotine dependence	0.00157	0.0273	CcSEcCtD
Molindone—HTR7—Monoamine GPCRs—DRD2—nicotine dependence	0.00154	0.029	CbGpPWpGaD
Molindone—Dry mouth—Varenicline—nicotine dependence	0.00142	0.0248	CcSEcCtD
Molindone—Tachycardia—Varenicline—nicotine dependence	0.00136	0.0237	CcSEcCtD
Molindone—Hypotension—Varenicline—nicotine dependence	0.0013	0.0227	CcSEcCtD
Molindone—HTR7—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00129	0.0244	CbGpPWpGaD
Molindone—Dyspnoea—Varenicline—nicotine dependence	0.00124	0.0216	CcSEcCtD
Molindone—Somnolence—Varenicline—nicotine dependence	0.00124	0.0216	CcSEcCtD
Molindone—Constipation—Varenicline—nicotine dependence	0.00119	0.0208	CcSEcCtD
Molindone—HTR1A—Monoamine GPCRs—DRD2—nicotine dependence	0.00114	0.0215	CbGpPWpGaD
Molindone—HTR2A—Monoamine GPCRs—DRD2—nicotine dependence	0.000986	0.0186	CbGpPWpGaD
Molindone—CHRM1—Monoamine GPCRs—DRD2—nicotine dependence	0.000981	0.0185	CbGpPWpGaD
Molindone—HTR1A—Amine ligand-binding receptors—DRD2—nicotine dependence	0.000959	0.0181	CbGpPWpGaD
Molindone—ADRA2A—Monoamine GPCRs—DRD2—nicotine dependence	0.000897	0.0169	CbGpPWpGaD
Molindone—Rash—Varenicline—nicotine dependence	0.000879	0.0153	CcSEcCtD
Molindone—Dermatitis—Varenicline—nicotine dependence	0.000878	0.0153	CcSEcCtD
Molindone—HTR2A—Amine ligand-binding receptors—DRD2—nicotine dependence	0.000829	0.0156	CbGpPWpGaD
Molindone—Nausea—Varenicline—nicotine dependence	0.000828	0.0144	CcSEcCtD
Molindone—CHRM1—Amine ligand-binding receptors—DRD2—nicotine dependence	0.000824	0.0155	CbGpPWpGaD
Molindone—HTR1A—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.000779	0.0147	CbGpPWpGaD
Molindone—CHRM1—cardiovascular system—nicotine dependence	0.000768	0.118	CbGeAlD
Molindone—CHRM1—Regulation of Actin Cytoskeleton—FGD1—nicotine dependence	0.000756	0.0142	CbGpPWpGaD
Molindone—ADRA2A—Amine ligand-binding receptors—DRD2—nicotine dependence	0.000754	0.0142	CbGpPWpGaD
Molindone—HTR1A—cardiovascular system—nicotine dependence	0.000685	0.105	CbGeAlD
Molindone—DRD2—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.000684	0.0129	CbGpPWpGaD
Molindone—HTR1A—SIDS Susceptibility Pathways—CHRNB4—nicotine dependence	0.000668	0.0126	CbGpPWpGaD
Molindone—HTR7—cardiovascular system—nicotine dependence	0.000654	0.1	CbGeAlD
Molindone—HTR7—GPCR ligand binding—TAS2R16—nicotine dependence	0.000636	0.012	CbGpPWpGaD
Molindone—ADRA2A—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.000612	0.0115	CbGpPWpGaD
Molindone—HTR2A—SIDS Susceptibility Pathways—CHRNB4—nicotine dependence	0.000577	0.0109	CbGpPWpGaD
Molindone—HTR1A—midbrain—nicotine dependence	0.000535	0.0821	CbGeAlD
Molindone—HTR7—midbrain—nicotine dependence	0.000511	0.0785	CbGeAlD
Molindone—HTR7—Circadian rythm related genes—CHRNB2—nicotine dependence	0.000491	0.00925	CbGpPWpGaD
Molindone—DRD2—midbrain—nicotine dependence	0.000483	0.0742	CbGeAlD
Molindone—HTR1A—GPCR ligand binding—TAS2R16—nicotine dependence	0.000471	0.00888	CbGpPWpGaD
Molindone—CHRM1—Regulation of Actin Cytoskeleton—WASF2—nicotine dependence	0.00047	0.00887	CbGpPWpGaD
Molindone—CHRM1—Regulation of Actin Cytoskeleton—WASF1—nicotine dependence	0.000451	0.0085	CbGpPWpGaD
Molindone—HTR1A—SIDS Susceptibility Pathways—CHRNB2—nicotine dependence	0.000445	0.0084	CbGpPWpGaD
Molindone—DRD2—GPCR ligand binding—TAS2R16—nicotine dependence	0.000414	0.0078	CbGpPWpGaD
Molindone—HTR7—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000411	0.00775	CbGpPWpGaD
Molindone—HTR2A—cardiovascular system—nicotine dependence	0.000408	0.0627	CbGeAlD
Molindone—HTR2A—GPCR ligand binding—TAS2R16—nicotine dependence	0.000407	0.00768	CbGpPWpGaD
Molindone—CHRM1—GPCR ligand binding—TAS2R16—nicotine dependence	0.000405	0.00763	CbGpPWpGaD
Molindone—HTR1A—SIDS Susceptibility Pathways—CHRNA4—nicotine dependence	0.000404	0.00762	CbGpPWpGaD
Molindone—HTR2A—SIDS Susceptibility Pathways—CHRNB2—nicotine dependence	0.000385	0.00725	CbGpPWpGaD
Molindone—CHRM1—brain—nicotine dependence	0.000377	0.0579	CbGeAlD
Molindone—ADRA2A—midbrain—nicotine dependence	0.000375	0.0576	CbGeAlD
Molindone—ADRA2A—GPCR ligand binding—TAS2R16—nicotine dependence	0.000371	0.00698	CbGpPWpGaD
Molindone—HTR7—Circadian rythm related genes—DRD2—nicotine dependence	0.000363	0.00684	CbGpPWpGaD
Molindone—HTR7—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00036	0.00678	CbGpPWpGaD
Molindone—HTR7—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000352	0.00664	CbGpPWpGaD
Molindone—HTR2A—SIDS Susceptibility Pathways—CHRNA4—nicotine dependence	0.000349	0.00659	CbGpPWpGaD
Molindone—HTR1A—brain—nicotine dependence	0.000336	0.0516	CbGeAlD
Molindone—HTR1A—G alpha (i) signalling events—OPRM1—nicotine dependence	0.000328	0.00619	CbGpPWpGaD
Molindone—HTR7—Signaling by GPCR—TAS2R16—nicotine dependence	0.000326	0.00615	CbGpPWpGaD
Molindone—HTR7—brain—nicotine dependence	0.000321	0.0493	CbGeAlD
Molindone—DRD2—Circadian rythm related genes—CHRNB2—nicotine dependence	0.000319	0.00602	CbGpPWpGaD
Molindone—HTR2A—midbrain—nicotine dependence	0.000319	0.0489	CbGeAlD
Molindone—CHRM1—Circadian rythm related genes—CHRNB2—nicotine dependence	0.000313	0.00589	CbGpPWpGaD
Molindone—HTR1A—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000305	0.00574	CbGpPWpGaD
Molindone—DRD2—brain—nicotine dependence	0.000304	0.0466	CbGeAlD
Molindone—HTR7—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000297	0.0056	CbGpPWpGaD
Molindone—DRD2—G alpha (i) signalling events—OPRM1—nicotine dependence	0.000288	0.00543	CbGpPWpGaD
Molindone—HTR7—GPCR downstream signaling—FGD1—nicotine dependence	0.000282	0.00532	CbGpPWpGaD
Molindone—HTR7—GPCR ligand binding—OPRM1—nicotine dependence	0.000268	0.00505	CbGpPWpGaD
Molindone—DRD2—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000267	0.00504	CbGpPWpGaD
Molindone—HTR1A—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000266	0.00502	CbGpPWpGaD
Molindone—HTR2A—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000263	0.00496	CbGpPWpGaD
Molindone—CHRM1—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000262	0.00493	CbGpPWpGaD
Molindone—HTR1A—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000261	0.00492	CbGpPWpGaD
Molindone—ADRA2A—G alpha (i) signalling events—OPRM1—nicotine dependence	0.000258	0.00486	CbGpPWpGaD
Molindone—HTR7—Signaling by GPCR—FGD1—nicotine dependence	0.000256	0.00483	CbGpPWpGaD
Molindone—HTR7—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000255	0.0048	CbGpPWpGaD
Molindone—HTR1A—Signaling by GPCR—TAS2R16—nicotine dependence	0.000242	0.00456	CbGpPWpGaD
Molindone—ADRA2A—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000239	0.00451	CbGpPWpGaD
Molindone—HTR1A—G alpha (i) signalling events—DRD2—nicotine dependence	0.000237	0.00447	CbGpPWpGaD
Molindone—ADRA2A—brain—nicotine dependence	0.000235	0.0362	CbGeAlD
Molindone—DRD2—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000234	0.00441	CbGpPWpGaD
Molindone—CHRM1—Circadian rythm related genes—DRD2—nicotine dependence	0.000231	0.00435	CbGpPWpGaD
Molindone—HTR2A—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00023	0.00434	CbGpPWpGaD
Molindone—DRD2—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000229	0.00432	CbGpPWpGaD
Molindone—CHRM1—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000229	0.00431	CbGpPWpGaD
Molindone—HTR2A—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000225	0.00425	CbGpPWpGaD
Molindone—CHRM1—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000224	0.00423	CbGpPWpGaD
Molindone—HTR1A—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00022	0.00415	CbGpPWpGaD
Molindone—DRD2—Signaling by GPCR—TAS2R16—nicotine dependence	0.000212	0.004	CbGpPWpGaD
Molindone—ADRA2A—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000209	0.00395	CbGpPWpGaD
Molindone—HTR1A—GPCR downstream signaling—FGD1—nicotine dependence	0.000209	0.00394	CbGpPWpGaD
Molindone—HTR2A—Signaling by GPCR—TAS2R16—nicotine dependence	0.000209	0.00394	CbGpPWpGaD
Molindone—CHRM1—Signaling by GPCR—TAS2R16—nicotine dependence	0.000208	0.00392	CbGpPWpGaD
Molindone—ADRA2A—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000205	0.00387	CbGpPWpGaD
Molindone—HTR2A—brain—nicotine dependence	0.0002	0.0308	CbGeAlD
Molindone—HTR1A—GPCR ligand binding—OPRM1—nicotine dependence	0.000199	0.00375	CbGpPWpGaD
Molindone—HTR7—GPCR ligand binding—DRD2—nicotine dependence	0.000194	0.00365	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—TAS2R16—nicotine dependence	0.000193	0.00363	CbGpPWpGaD
Molindone—HTR2A—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00019	0.00359	CbGpPWpGaD
Molindone—ADRA2A—Signaling by GPCR—TAS2R16—nicotine dependence	0.00019	0.00358	CbGpPWpGaD
Molindone—HTR1A—Signaling by GPCR—FGD1—nicotine dependence	0.00019	0.00358	CbGpPWpGaD
Molindone—CHRM1—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000189	0.00357	CbGpPWpGaD
Molindone—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000189	0.00356	CbGpPWpGaD
Molindone—ADRA2A—G alpha (i) signalling events—DRD2—nicotine dependence	0.000187	0.00352	CbGpPWpGaD
Molindone—DRD2—GPCR downstream signaling—FGD1—nicotine dependence	0.000184	0.00346	CbGpPWpGaD
Molindone—HTR2A—GPCR downstream signaling—FGD1—nicotine dependence	0.000181	0.0034	CbGpPWpGaD
Molindone—CHRM1—GPCR downstream signaling—FGD1—nicotine dependence	0.00018	0.00339	CbGpPWpGaD
Molindone—DRD2—GPCR ligand binding—OPRM1—nicotine dependence	0.000174	0.00329	CbGpPWpGaD
Molindone—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000173	0.00326	CbGpPWpGaD
Molindone—HTR2A—GPCR ligand binding—OPRM1—nicotine dependence	0.000172	0.00324	CbGpPWpGaD
Molindone—CHRM1—GPCR ligand binding—OPRM1—nicotine dependence	0.000171	0.00322	CbGpPWpGaD
Molindone—DRD2—Signaling by GPCR—FGD1—nicotine dependence	0.000167	0.00314	CbGpPWpGaD
Molindone—ADRA2A—GPCR downstream signaling—FGD1—nicotine dependence	0.000164	0.0031	CbGpPWpGaD
Molindone—HTR2A—Signaling by GPCR—FGD1—nicotine dependence	0.000164	0.00309	CbGpPWpGaD
Molindone—CHRM1—Signaling by GPCR—FGD1—nicotine dependence	0.000163	0.00307	CbGpPWpGaD
Molindone—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000163	0.00307	CbGpPWpGaD
Molindone—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000162	0.00306	CbGpPWpGaD
Molindone—ADRA2A—GPCR ligand binding—OPRM1—nicotine dependence	0.000156	0.00294	CbGpPWpGaD
Molindone—HTR7—GPCR downstream signaling—OPRM1—nicotine dependence	0.000152	0.00286	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—FGD1—nicotine dependence	0.000151	0.00285	CbGpPWpGaD
Molindone—ADRA2A—Signaling by GPCR—FGD1—nicotine dependence	0.000149	0.00281	CbGpPWpGaD
Molindone—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000148	0.00279	CbGpPWpGaD
Molindone—HTR1A—GPCR ligand binding—DRD2—nicotine dependence	0.000144	0.00271	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—TAS2R16—nicotine dependence	0.000143	0.00269	CbGpPWpGaD
Molindone—HTR7—Signaling by GPCR—OPRM1—nicotine dependence	0.000138	0.00259	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—AKR1B10—nicotine dependence	0.000134	0.00252	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—TAS2R16—nicotine dependence	0.000125	0.00236	CbGpPWpGaD
Molindone—HTR2A—GPCR ligand binding—DRD2—nicotine dependence	0.000124	0.00234	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—TAS2R16—nicotine dependence	0.000123	0.00233	CbGpPWpGaD
Molindone—CHRM1—GPCR ligand binding—DRD2—nicotine dependence	0.000123	0.00233	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—TAS2R16—nicotine dependence	0.000123	0.00231	CbGpPWpGaD
Molindone—ADRA2A—GPCR ligand binding—DRD2—nicotine dependence	0.000113	0.00213	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—TAS2R16—nicotine dependence	0.000112	0.00212	CbGpPWpGaD
Molindone—HTR1A—GPCR downstream signaling—OPRM1—nicotine dependence	0.000112	0.00212	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—FGD1—nicotine dependence	0.000112	0.00211	CbGpPWpGaD
Molindone—HTR7—GPCR downstream signaling—DRD2—nicotine dependence	0.00011	0.00207	CbGpPWpGaD
Molindone—HTR1A—Signaling by GPCR—OPRM1—nicotine dependence	0.000102	0.00192	CbGpPWpGaD
Molindone—HTR7—Signaling by GPCR—DRD2—nicotine dependence	9.95e-05	0.00188	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—AKR1B10—nicotine dependence	9.91e-05	0.00187	CbGpPWpGaD
Molindone—DRD2—GPCR downstream signaling—OPRM1—nicotine dependence	9.86e-05	0.00186	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—FGD1—nicotine dependence	9.85e-05	0.00186	CbGpPWpGaD
Molindone—HTR2A—GPCR downstream signaling—OPRM1—nicotine dependence	9.7e-05	0.00183	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—FGD1—nicotine dependence	9.69e-05	0.00183	CbGpPWpGaD
Molindone—CHRM1—GPCR downstream signaling—OPRM1—nicotine dependence	9.65e-05	0.00182	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—FGD1—nicotine dependence	9.64e-05	0.00182	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—WASF2—nicotine dependence	9.42e-05	0.00178	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—WASF1—nicotine dependence	9.03e-05	0.0017	CbGpPWpGaD
Molindone—DRD2—Signaling by GPCR—OPRM1—nicotine dependence	8.95e-05	0.00169	CbGpPWpGaD
Molindone—ADRA2A—GPCR downstream signaling—OPRM1—nicotine dependence	8.83e-05	0.00166	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—FGD1—nicotine dependence	8.81e-05	0.00166	CbGpPWpGaD
Molindone—HTR2A—Signaling by GPCR—OPRM1—nicotine dependence	8.81e-05	0.00166	CbGpPWpGaD
Molindone—CHRM1—Signaling by GPCR—OPRM1—nicotine dependence	8.76e-05	0.00165	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—AKR1B10—nicotine dependence	8.7e-05	0.00164	CbGpPWpGaD
Molindone—ADRA2A—Metabolism—CYP2A7—nicotine dependence	8.66e-05	0.00163	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—AKR1B10—nicotine dependence	8.56e-05	0.00161	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—AKR1B10—nicotine dependence	8.51e-05	0.0016	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—OPRM1—nicotine dependence	8.13e-05	0.00153	CbGpPWpGaD
Molindone—HTR1A—GPCR downstream signaling—DRD2—nicotine dependence	8.12e-05	0.00153	CbGpPWpGaD
Molindone—ADRA2A—Signaling by GPCR—OPRM1—nicotine dependence	8.02e-05	0.00151	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—AKR1B10—nicotine dependence	7.79e-05	0.00147	CbGpPWpGaD
Molindone—HTR1A—Signaling by GPCR—DRD2—nicotine dependence	7.37e-05	0.00139	CbGpPWpGaD
Molindone—HTR2A—GPCR downstream signaling—DRD2—nicotine dependence	7.01e-05	0.00132	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—WASF2—nicotine dependence	6.98e-05	0.00132	CbGpPWpGaD
Molindone—CHRM1—GPCR downstream signaling—DRD2—nicotine dependence	6.98e-05	0.00131	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—WASF1—nicotine dependence	6.69e-05	0.00126	CbGpPWpGaD
Molindone—ADRA2A—GPCR downstream signaling—DRD2—nicotine dependence	6.38e-05	0.0012	CbGpPWpGaD
Molindone—HTR2A—Signaling by GPCR—DRD2—nicotine dependence	6.37e-05	0.0012	CbGpPWpGaD
Molindone—CHRM1—Signaling by GPCR—DRD2—nicotine dependence	6.34e-05	0.00119	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—WASF2—nicotine dependence	6.13e-05	0.00115	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—WASF2—nicotine dependence	6.03e-05	0.00114	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—OPRM1—nicotine dependence	6.03e-05	0.00114	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—WASF2—nicotine dependence	6e-05	0.00113	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—DRD2—nicotine dependence	5.88e-05	0.00111	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—WASF1—nicotine dependence	5.88e-05	0.00111	CbGpPWpGaD
Molindone—ADRA2A—Signaling by GPCR—DRD2—nicotine dependence	5.8e-05	0.00109	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—WASF1—nicotine dependence	5.78e-05	0.00109	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—WASF1—nicotine dependence	5.75e-05	0.00108	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—WASF2—nicotine dependence	5.49e-05	0.00103	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—OPRM1—nicotine dependence	5.29e-05	0.000997	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—WASF1—nicotine dependence	5.26e-05	0.000991	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—OPRM1—nicotine dependence	5.21e-05	0.000981	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—OPRM1—nicotine dependence	5.18e-05	0.000976	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—OPRM1—nicotine dependence	4.74e-05	0.000892	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—DRD2—nicotine dependence	4.36e-05	0.000821	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—DRD2—nicotine dependence	3.76e-05	0.000709	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—DRD2—nicotine dependence	3.74e-05	0.000705	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—DRD2—nicotine dependence	3.42e-05	0.000645	CbGpPWpGaD
